Arkolith/Insider Trading/CERE/Form 4

Coles N Anthony

DirectorCerevel Therapeutics Holdings, Inc. (CERE) · full profile →Form 4 · filed Mar 6, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.1M
Net Open-Market Flow
-$2.1M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2024Option exercise(M)50K$3.50$175K66K
Mar 4, 2024Sell(S)50K$41.01$2.1M16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2024Option exercise(M)50K—$02.4M

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-027156) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML